Since the finding on the varied expression of PPAR-γ in cancer of different differentiation stages and its involvement in cell proliferation, however, ciglitazone has been striving to make a comeback into the medical field as a novel potential anti-tumor agent. The gene discussed is PPARG; the disease is cancer.